Tezepelumab as add‐on treatment for severe asthma.
- Published in:
- Prescriber, 2023, v. 34, n. 3, p. 13, doi. 10.1002/psb.2050
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2023 AND VI 34 AND IP 3
Results: 5
1
2
Prescribing Skills Assessment.
- Published in:
- Prescriber, 2023, v. 34, n. 3, p. 11, doi. 10.1002/psb.2049
- Publication type:
- Article
3
SIGN updates its guideline on the management of migraine.
- Published in:
- Prescriber, 2023, v. 34, n. 3, p. 9, doi. 10.1002/psb.2048
- By:
- Publication type:
- Article
4
mRNA anti‐cancer vaccine research gains momentum.
- Published in:
- Prescriber, 2023, v. 34, n. 3, p. 5, doi. 10.1002/psb.2047
- By:
- Publication type:
- Article
5
New therapeutic technology, new hope.
- Published in:
- Prescriber, 2023, v. 34, n. 3, p. 4, doi. 10.1002/psb.2046
- Publication type:
- Article